Lincoln Pharmaceuticals Market Cap

Lincoln Pharmaceuticals has a market cap or net worth of 10.97 billion as of July 15, 2025. Its market cap has decreased by -10.32% in one year.

Market Cap

10.97B

Enterprise Value

9.01B

Revenue

6.23B

Ranking

n/a

PE Ratio

13.32

Stock Price

558.05

Market Cap Chart

Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 10.97B, an increase of 7,798.42%. That is a compound annual growth rate of 23.45%.

Market Cap History

Date	Market Cap	% Change
Jul 14, 2025	10.97B	-30.42%
Dec 31, 2024	15.77B	29.24%
Dec 29, 2023	12.20B	71.47%
Dec 30, 2022	7.12B	-0.74%
Dec 31, 2021	7.17B	47.47%
Dec 31, 2020	4.86B	18.73%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,037.12B
Divi's Laboratories	1,814.48B
Cipla	1,198.64B
Mankind Pharma	1,112.92B
Apollo Hospitals Enterprise	1,038.13B
Zydus Lifesciences	974.49B
Aurobindo Pharma	661.30B
Glenmark Pharmaceuticals	615.51B

Market Cap Rankings